Skip to main content Skip to section navigation Skip to footer
Back to checkpointtx.com

Checkpoint Therapeutics, Inc.

Investor Relations
  • Investors
  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
Nov 13, 2023

Checkpoint Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Oct 18, 2023

Checkpoint Therapeutics Announces Publication of Cosibelimab Pivotal Trial Results in the Journal for ImmunoTherapy of Cancer

Oct 02, 2023

Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds

Sep 21, 2023

Checkpoint Therapeutics to Participate in the Cantor Global Healthcare Conference

Sep 06, 2023

Checkpoint Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference

Aug 14, 2023

Checkpoint Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights

Jul 31, 2023

Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market

Jul 27, 2023

Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results Demonstrating Substantial Increases in Complete Response Rates in Advanced Cutaneous Squamous Cell Carcinoma

Jun 28, 2023

Checkpoint Therapeutics Announces Presentation of New Cosibelimab Pharmacokinetic Data Supporting Extended-Interval Dosing

May 23, 2023

Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …13
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
©2025 Checkpoint Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap

Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.